Beiersdorf and Terumo to set up joint venture:
This article was originally published in Clinica
Executive Summary
The German company, Beiersdorf, is to start a cooperation agreement with the Japanese company, Terumo, from April 1 1998. The two companies plan to form a 50:50 joint venture later this year. Under the agreement, the joint venture will import and market Beiersdorf's wound care and phlebology products for hospital use. Tokyo-based Terumo will handle sales in Japan. Beiersdorf's Japanese subsidiary, which formerly marketed the products, will now concentrate on selling the company's industrial products.
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.